These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 21562285)

  • 1. The parkinsonian mimetic, MPP+, specifically impairs mitochondrial transport in dopamine axons.
    Kim-Han JS; Antenor-Dorsey JA; O'Malley KL
    J Neurosci; 2011 May; 31(19):7212-21. PubMed ID: 21562285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Parkinsonian mimetic, 6-OHDA, impairs axonal transport in dopaminergic axons.
    Lu X; Kim-Han JS; Harmon S; Sakiyama-Elbert SE; O'Malley KL
    Mol Neurodegener; 2014 May; 9():17. PubMed ID: 24885281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Live imaging of mitochondrial dynamics in CNS dopaminergic neurons in vivo demonstrates early reversal of mitochondrial transport following MPP(+) exposure.
    Dukes AA; Bai Q; Van Laar VS; Zhou Y; Ilin V; David CN; Agim ZS; Bonkowsky JL; Cannon JR; Watkins SC; Croix CM; Burton EA; Berman SB
    Neurobiol Dis; 2016 Nov; 95():238-49. PubMed ID: 27452482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effect of catecholamines and MPP(+) on membrane permeability in brain mitochondria and cell viability in PC12 cells.
    Lee CS; Han JH; Jang YY; Song JH; Han ES
    Neurochem Int; 2002 Apr; 40(4):361-9. PubMed ID: 11792467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Release of dopamine by perfusion with 1-methyl-4-phenylpyridinium ion (MPP(+)) into the striatum is associated with hydroxyl free radical generation.
    Obata T; Yamanaka Y; Kinemuchi H; Oreland L
    Brain Res; 2001 Jul; 906(1-2):170-5. PubMed ID: 11430875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated Mitochondrial Bioenergetics and Axonal Arborization Size Are Key Contributors to the Vulnerability of Dopamine Neurons.
    Pacelli C; Giguère N; Bourque MJ; Lévesque M; Slack RS; Trudeau LÉ
    Curr Biol; 2015 Sep; 25(18):2349-60. PubMed ID: 26320949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DLP1-dependent mitochondrial fragmentation mediates 1-methyl-4-phenylpyridinium toxicity in neurons: implications for Parkinson's disease.
    Wang X; Su B; Liu W; He X; Gao Y; Castellani RJ; Perry G; Smith MA; Zhu X
    Aging Cell; 2011 Oct; 10(5):807-23. PubMed ID: 21615675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity.
    Lotharius J; O'Malley KL
    J Biol Chem; 2000 Dec; 275(49):38581-8. PubMed ID: 10969076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in neuronal dopamine homeostasis following 1-methyl-4-phenylpyridinium (MPP+) exposure.
    Choi SJ; Panhelainen A; Schmitz Y; Larsen KE; Kanter E; Wu M; Sulzer D; Mosharov EV
    J Biol Chem; 2015 Mar; 290(11):6799-809. PubMed ID: 25596531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism.
    Cassarino DS; Parks JK; Parker WD; Bennett JP
    Biochim Biophys Acta; 1999 Jan; 1453(1):49-62. PubMed ID: 9989245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-Methyl-4-phenylpyridinium affects fast axonal transport by activation of caspase and protein kinase C.
    Morfini G; Pigino G; Opalach K; Serulle Y; Moreira JE; Sugimori M; Llinás RR; Brady ST
    Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2442-7. PubMed ID: 17287338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyl-4-phenylpyridinium (MPP+) differentially affects monoamine release and re-uptake in murine embryonic stem cell-derived dopaminergic and serotonergic neurons.
    Martí Y; Matthaeus F; Lau T; Schloss P
    Mol Cell Neurosci; 2017 Sep; 83():37-45. PubMed ID: 28673772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for hydroxyl radical scavenging action of nitric oxide donors in the protection against 1-methyl-4-phenylpyridinium-induced neurotoxicity in rats.
    Banerjee R; Saravanan KS; Thomas B; Sindhu KM; Mohanakumar KP
    Neurochem Res; 2008 Jun; 33(6):985-95. PubMed ID: 17763941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Protective effects of Lycium barbarum extract against MPP(+) -induced neurotoxicity in Caenorhabditis elegans and PC12 cells].
    Yao XL; Wu WL; Zheng MY; Li W; Ye CH; Lu XL
    Zhong Yao Cai; 2011 Aug; 34(8):1241-6. PubMed ID: 22233040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MPP+-induced increases in extracellular potassium ion activity in rat striatal slices suggest that consequences of MPP+ neurotoxicity are spread beyond dopaminergic terminals.
    Hollinden GE; Sanchez-Ramos JR; Sick TJ; Rosenthal M
    Brain Res; 1988 Dec; 475(2):283-90. PubMed ID: 3265070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection from 1-methyl-4-phenylpyridinium (MPP+) toxicity and stimulation of regrowth of MPP(+)-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF.
    Park TH; Mytilineou C
    Brain Res; 1992 Dec; 599(1):83-97. PubMed ID: 1362921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis inducing factor mediates caspase-independent 1-methyl-4-phenylpyridinium toxicity in dopaminergic cells.
    Chu CT; Zhu JH; Cao G; Signore A; Wang S; Chen J
    J Neurochem; 2005 Sep; 94(6):1685-95. PubMed ID: 16156740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel inhibits mRNA transport in axons.
    Bobylev I; Joshi AR; Barham M; Ritter C; Neiss WF; Höke A; Lehmann HC
    Neurobiol Dis; 2015 Oct; 82():321-331. PubMed ID: 26188177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pramipexole reduces reactive oxygen species production in vivo and in vitro and inhibits the mitochondrial permeability transition produced by the parkinsonian neurotoxin methylpyridinium ion.
    Cassarino DS; Fall CP; Smith TS; Bennett JP
    J Neurochem; 1998 Jul; 71(1):295-301. PubMed ID: 9648878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined effect of dopamine and MPP+ on membrane permeability in mitochondria and cell viability in PC12 cells.
    Lee CS; Song EH; Park SY; Han ES
    Neurochem Int; 2003 Jul; 43(2):147-54. PubMed ID: 12620283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.